04/16/2024 11:16 AM | Johnson & Johnson (Filer)
| Form 8-K/A | |
04/16/2024 6:06 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/10/2024 4:05 PM | Contineum Therapeutics, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
04/10/2024 4:12 PM | Contineum Therapeutics, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G | |
04/05/2024 4:29 PM | Johnson & Johnson (Filed by) Shockwave Medical, Inc. (Subject)
| Form DFAN14A | |
03/27/2024 8:48 AM | Johnson & Johnson (Subject) National Legal & Policy Center (Filed by)
| Form PX14A6G | |
03/13/2024 3:28 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
|
03/13/2024 3:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/13/2024 6:42 AM | Johnson & Johnson (Filer)
| Form ARS | |
03/13/2024 6:35 AM | Johnson & Johnson (Filer)
| Form DEF 14A | |
03/13/2024 6:37 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/13/2024 6:39 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
03/06/2024 2:42 PM | CVRx, Inc. (Issuer) Johnson & Johnson (Reporting) Johnson & Johnson Innovation - JJDC, Inc. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:58 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/20/2024 4:54 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/16/2024 3:12 PM | Johnson & Johnson (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/15/2024 4:23 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
02/15/2024 3:53 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/15/2024 3:53 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 5:36 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Decker Robert J (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Broadhurst Vanessa (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:24 PM | Johnson & Johnson (Issuer) Swanson James D. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share (Ad) The latest flare-up between Israel and Palestinian militants has sent gold prices surging.
Why? Because savvy investors know the endgame of the elites at play…
Geopolitical crises breed uncertainty — and gold thrives on uncertainty.
See why the elites are pouring billions into gold. |
02/12/2024 6:24 PM | Forminard Elizabeth (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wolk Joseph J (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Wengel Kathryn E (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Duato Joaquin (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/12/2024 6:25 PM | Johnson & Johnson (Issuer) Taubert Jennifer L (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/09/2024 11:55 AM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/09/2024 11:35 AM | Johnson & Johnson (Subject) Taubert Jennifer L (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/06/2024 3:24 PM | Johnson & Johnson (Subject) McEvoy Ashley (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
02/02/2024 4:07 PM | BiomX Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:52 PM | CVRx, Inc. (Subject) Johnson & Johnson (Filed by)
| Form SC 13G/A | |
02/02/2024 3:32 PM | Johnson & Johnson (Filed by) Johnson & Johnson (Filed by) Nanobiotix S.A. (Subject)
| Form SC 13G/A | |
01/30/2024 11:46 AM | Johnson & Johnson (Subject) STATE STREET CORP (Filed by)
| Form SC 13G/A | |
01/29/2024 3:50 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/24/2024 11:51 AM | Johnson & Johnson (Filed by) Kenvue Inc. (Subject)
| Form SC 13G | |
01/23/2024 6:45 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/09/2024 4:08 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 4:22 PM | Ambrx Biopharma, Inc. (Subject) Johnson & Johnson (Filed by)
| Form DFAN14A | |
01/08/2024 7:22 AM | Johnson & Johnson (Filer)
| Form DEFA14A | |
12/08/2023 3:33 PM | Johnson & Johnson (Issuer) Woods Eugene A. (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/07/2023 4:17 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:42 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/05/2023 6:52 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/30/2023 3:30 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/27/2023 3:56 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/02/2023 3:36 PM | Johnson & Johnson (Issuer) Schmid Timothy (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
10/23/2023 3:48 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/17/2023 6:33 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/11/2023 3:36 PM | HEWSON MARILLYN A (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/30/2023 6:46 AM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 4:02 PM | Johnson & Johnson (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/25/2023 3:53 PM | Johnson & Johnson (Reporting) Kenvue Inc. (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/23/2023 6:04 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/23/2023 5:37 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/21/2023 5:52 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/21/2023 5:38 AM | Johnson & Johnson (Subject)
| Form 425 | |
08/18/2023 4:11 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 3:53 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/17/2023 5:23 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/16/2023 8:22 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/16/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/15/2023 3:43 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/14/2023 3:44 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/11/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/04/2023 3:32 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
08/03/2023 7:03 AM | Johnson & Johnson (Subject)
| Form SC TO-I/A | |
08/01/2023 3:39 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/31/2023 3:06 PM | Johnson & Johnson (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/28/2023 7:59 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/27/2023 4:52 PM | Hait William (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
The Gold Grab of the Century (Ad) When central banks buy gold…
The rich buy right along with them.
And central banks are buying at breakneck pace.
Last year… 1,037 tons.
Just 45 tons less than the record set two years ago. That's why we have released our Free Precious Metals Investment Guide. |
07/27/2023 4:52 PM | Fasolo Peter (Reporting) Johnson & Johnson (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/24/2023 3:51 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject) Kenvue Inc. (Filed by)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:04 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |
07/24/2023 3:05 PM | Johnson & Johnson (Subject)
| Form 425 | |